Junhemeng Biopharmaceutical
Hangzhou
About Junhemeng Biopharmaceutical
Junhemeng Biopharmaceutical focuses on developing innovative synthetic biology products and recombinant protein drugs for endocrine, neurotherapy, anti-aging, and biomedical applications.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $56.7M
- Last round: Series Unknown (May 2025)
- Website: jhm-biopharma.comzh_cnindex
- Phone: +86 159-0041-7569
Industries & Categories
Biopharma, Biotechnology, Medical
Canonical: https://fsome.com/organization/junhemeng-biopharmaceutical-65017 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.